Skinvisible, Inc. (SKVI) stock
SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16+0.00 (+0.06%)
Close on Oct 19, 2026Market cap $843.54KP/E –Yield –
Skinvisible price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Skinvisible's price to sales ratio was 42.2× on Oct 19, 2026, against 135.4× a year earlier. Over the last 5 years it ranged from 0.7× to 189.0×, with a median of 40.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 42.2× | −20.1 |
| 2025 | Dec 31, 2025 | 62.3× | −20.1 |
| 2024 | Dec 31, 2024 | 82.4× | +63.4 |
| 2023 | Dec 29, 2023 | 19.0× | +18.3 |
| 2022 | Dec 30, 2022 | 0.7× | −1.3 |
| 2021 | Dec 31, 2021 | 2.0× | −5.4 |
| 2020 | Dec 31, 2020 | 7.4× | +1.5 |
| 2019 | Dec 31, 2019 | 5.9× | −6.0 |
| 2018 | Dec 31, 2018 | 11.9× | −24.7 |
| 2017 | Dec 29, 2017 | 36.6× | +17.9 |
| 2016 | Dec 30, 2016 | 18.7× | −1.0 |
| 2015 | Dec 31, 2015 | 19.7× | −66.1 |
| 2014 | Dec 31, 2014 | 85.7× | +76.0 |
| 2013 | Dec 31, 2013 | 9.7× | −32.6 |
| 2012 | Dec 31, 2012 | 42.3× | +2.4 |
| 2011 | Dec 30, 2011 | 39.9× | – |
See a number that looks wrong?